Home › Adrenocortical Carcinoma
Adrenocortical Carcinoma clinical trials recruiting in the U.S.
9 studies for Adrenocortical Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 29, 2026 · NCT06487481Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 18, 2026 · NCT06900595PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Sep 2, 2026 · NCT05286814Familial Investigations of Childhood Cancer Predisposition
RecruitingObservational study
All ages · All sexes · Updated Jun 17, 2026 · NCT03050268A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Jun 15, 2026 · NCT06041516A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT07189403Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06066333Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT06006013From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.